Insider sale
WEREWOLF THERAPEUTICS, INC.
$99.0K
202.03K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 202.03K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $99.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/28/2026ACC: 0001628280-26-038893
10% Owner
Since Apr 2021
202.03K
Shares to sell
$99.0K
Approx. market value
202.03K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
202.03KTotal acquired202.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 202.03K | — |
| Total | 202.03K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
202.03K
Market value
$99.0K
5/28/2026
Total
Units
202.03K
Value
$99.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/28/2026 | 202.03K | $99.0K | NASDAQ | Planned |
| Total | 202.03K | $99.0K | ||